UT MD Anderson Cancer Center

04/17/2026

Your immune system can recognize cancer, and researchers are working to make that response even stronger.

Natural killer cells help identify abnormal cells. At UT MD Anderson, researchers are enhancing these cells by combining them with T cell receptor technology to improve how they detect and respond to cancer more precisely.

Watch to learn more.

04/16/2026

After two tongue cancer surgeries, Jessica Lutterman faced the possibility of a third procedure that could further impact her quality of life.

She came to UT MD Anderson and enrolled in a clinical trial led by Dr. Moran Amit, exploring an investigational immunotherapy approach for high-risk precancerous lesions in the oral cavity.

After treatment, a biopsy of the treated area showed no remaining precancerous cells.

Jessica continues to be followed by her care team and is now supporting research she hopes will expand options and preserve quality of life for future patients.

Read her story: http://spr.ly/6181B640bd

04/16/2026

Cancer research is moving fast, and new discoveries are helping bring better treatments to patients sooner.

In this Cancerwise Podcast episode, our Drs. Albert Koong and Nick Navin discuss how emerging biomarkers, new technologies and multimodal data are advancing precision oncology and improving care for patients with cancer.

Listen to the full episode at: http://spr.ly/6180B64daA or wherever you get your podcasts.

04/15/2026

What’s new in cancer research?

Three UT MD Anderson studies being shared at the 2026 American Association for Cancer Research Annual Meeting highlight advances in immunotherapy delivery, AI-driven prediction of treatment response in lung cancer and a novel targeted therapy combination for advanced cancers with specific genetic alterations.

These findings reflect ongoing efforts to better understand tumor biology and develop more precise, personalized treatments.

Read more: http://spr.ly/6183B64ZGz

Albert Koong, M.D., Ph.D., shares three abstracts that will be shared by UT MD Anderson researchers at the 2026 annual meeting of the American Association for Cancer Research. These breakthroughs in discovery science and translational research will move cancer therapies further for our patients.

04/14/2026

After years of clear scans, Roberto Gonzalez was surprised to learn his kidney cancer had returned as stage 4. He sought a second opinion to better understand his options and next steps.

With a treatment plan in place, he’s seeing his tumors shrink and focusing on what matters most, including time with his family.

“I have a beautiful life. I’ve had my hardships, but I’ve also had a tremendous number of blessings,” he says.

Read his story at the link in comments.

04/13/2026

Just two days before her 32nd birthday, Hannah Kahn learned she had a brain tumor.

She came to UT MD Anderson for care, where she underwent surgery, proton therapy and ongoing treatment with a team she trusted every step of the way. Today, she continues her care with confidence in her doctors and the plan ahead.

“I felt a sense of relief knowing I was going to be in the best hands,” she says.

Read her story: http://spr.ly/6183B6FA7R

04/13/2026

If you or someone you know has been diagnosed with leukemia, you may be hearing about a newer treatment option called menin inhibitors.

Dr. Elias Jabbour explains how these therapies work and how they are being used to treat certain types of leukemia.

Learn more about this emerging treatment approach: http://spr.ly/6189B6FACz

What are menin inhibitors? Leukemia expert Elias Jabbour, M.D., discusses which patients make the best candidates for this novel cancer therapy, how they work and possible side effects.

04/12/2026

Immunosuppressants play an important role in cancer care, especially for patients undergoing stem cell transplants.

Dr. Jeremy Ramdial explains how these drugs work, why they are used before and after transplant and how they help manage inflammation and reduce complications.

Learn more: http://spr.ly/6183B6Lzcd

What are immunosuppressants? Jeremy Ramdial, M.D., explains how these drugs work, their role in stem cell transplants, and how they help manage graft vs. host disease.

04/11/2026

When Savannah Curry was diagnosed with inflammatory breast cancer during pregnancy, she came to UT MD Anderson for specialized care.

With a coordinated treatment plan, she safely delivered a healthy baby boy and completed therapy. Today, she shows no evidence of disease.

She named her son Anderson to honor the care that supported her through every step.

Read her story: http://spr.ly/6189B6Lzil

04/10/2026

After facing oral cancer five times, Alex Harrison turned to UT MD Anderson for specialized care. Today, he is cancer-free and sharing what his experience has taught him.

He reflects on the importance of seeking a second opinion, starting with expert care and finding ways to move forward after treatment.

Read his advice: http://spr.ly/6181B6Lz9U

04/10/2026

Looking for a simple way to slow down this spring?

Try a relaxing drawing activity. Follow along with our step-by-step reel to learn how to draw a grasshopper and take a few minutes for yourself.

Creative moments like this can help you reset and recharge.

Watch and give it a try.

04/09/2026

Okra water is trending, with claims it can support everything from digestion to skin health. But does it actually live up to the hype?

Clinical Dietitian Rachel Murphy breaks down what the science says, including potential benefits and risks to consider before adding it to your routine.

Read more: http://spr.ly/6182B6I8P0

Is okra water actually good for you? Senior clinical dietician Rachel Murphy weighs in on the science behind the trend, from its alleged blood sugar and weight loss benefits to the potential risks.